Repligen (RGEN) Cash from Investing Activities (2010 - 2026)

Repligen's (RGEN) quarterly Cash from Investing Activities came in at -$4.0 million in Q1 2026, up 94.62% year-on-year from -$2.0 million in Q1 2025, and up 98.09% on a QoQ basis from -$208.7 million in Q4 2025.

Repligen (RGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Repligen (RGEN) has 17 years of Cash from Investing Activities data on file, last reported at -$4.0 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 94.62% year-over-year to -$4.0 million in Q1 2026; TTM through Mar 2026 was -$228.4 million, a 50.11% decrease from a year earlier, with the FY2025 full-year figure at -$298.5 million, down 245.52% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$4.0 million, up from -$208.7 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for RGEN reached as high as $64.8 million in Q2 2023 and fell as low as -$208.7 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$43.8 million across 5 years, with a median of -$9.4 million in 2023.
  • Across the five-year window, Cash from Investing Activities soared 347.27% in 2023 and tumbled 786.25% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$121.3 million in 2022, then slumped by 40.06% to -$169.9 million in 2023, then jumped by 61.88% to -$64.8 million in 2024, then sank by 222.32% to -$208.7 million in 2025, then jumped by 98.09% to -$4.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$4.0 million in Q1 2026, -$208.7 million in Q4 2025, and -$7.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -139.00 Mn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn -218.00 Mn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn -96.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn -58.03 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn -43.20 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn -77.00 Mn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -90.00 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn -131.58 Mn
10 Repligen 7.37 Bn 6.39 Bn 108.28 Mn -3.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.99 Mn
Mar 31, 2026 -3.99 Mn
Dec 31, 2025 -208.74 Mn
Dec 31, 2025 -208.74 Mn
Sep 30, 2025 -7.78 Mn
Sep 30, 2025 -7.78 Mn
Jun 30, 2025 -7.84 Mn
Jun 30, 2025 -7.84 Mn
Mar 31, 2025 -74.11 Mn
Mar 31, 2025 -74.11 Mn
Dec 31, 2024 -64.76 Mn
Dec 31, 2024 -64.76 Mn
Sep 30, 2024 -5.86 Mn
Sep 30, 2024 -5.86 Mn
Jun 30, 2024 -7.40 Mn
Jun 30, 2024 -7.40 Mn
Mar 31, 2024 -8.36 Mn
Mar 31, 2024 -8.36 Mn
Dec 31, 2023 -169.91 Mn
Dec 31, 2023 -169.91 Mn